ExodusPoint Capital Management, LP - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 131 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2023$1,466
+701.1%
83,572
+391.8%
0.01%
+400.0%
Q1 2023$183
-99.9%
16,994
-11.3%
0.00%0.0%
Q4 2021$225,000
-50.5%
19,157
-52.1%
0.00%
-66.7%
Q3 2021$455,00039,9870.01%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 30,000$560,1000.52%
ADIRONDACK TRUST CO 875$16,2660.01%
CWM, LLC 451$80.00%
BARCLAYS PLC 34,839$6500.00%
OSAIC HOLDINGS, INC. 623$11,6310.00%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders